Related Experiment Video
Updated: Jan 13, 2026

Quantifying Replication Stress in Ovarian Cancer Cells Using Single-Stranded DNA Immunofluorescence
Published on: February 10, 2023
RPA exhaustion activates SLFN11 to eliminate cells with heightened replication stress
Tyler H Stanage1, Shudong Li1, Sandra Segura-Bayona1
1DSB Repair Laboratory, The Francis Crick Institute, London, UK.
Abstract:
SLFN11 is epigenetically silenced and confers chemoresistance in half of all cancers. In response to replication stress, SLFN11 triggers translation shutdown and p53-independent apoptosis, but how DNA damage activates SLFN11 remains unclear. Here through CRISPR-based screens we implicate SLFN11 as the critical determinant of cisplatin sensitivity in cells lacking primase-polymerase (PrimPol)-mediated repriming. SLFN11 and the downstream integrated stress response uniquely promote cisplatin-driven apoptosis in PrimPol-deficient cells. We demonstrate that replication protein A (RPA) exhaustion and single-stranded DNA exposure trigger SLFN11 activation and cell death when PrimPol is inactivated. We further identify the USP1-WDR48 deubiquitinase complex as a positive modulator of SLFN11 activation in PrimPol-deficient cells, revealing an addiction to the Fanconi anaemia pathway to resolve cisplatin lesions. Finally, we demonstrate that rapid RPA exhaustion on chemical inhibition of DNA polymerase α activates SLFN11-dependent cell death. Together, our results implicate RPA exhaustion as a general mechanism to activate SLFN11 in response to heightened replication stress.
Insights
The study reveals that replication protein A (RPA) exhaustion triggers SLFN11 activation and cancer cell death, particularly when DNA repair pathways like PrimPol are deficient. This finding offers new insights into cancer chemotherapy resistance.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- The protein SLFN11 (ச்சாங்-லி-ஃபங்-11) is epigenetically silenced in many cancers, contributing to chemoresistance.
- SLFN11 activation leads to translation shutdown and apoptosis, but its DNA damage-induced activation mechanism is not fully understood.
Purpose of the Study:
- To elucidate the mechanism by which DNA damage activates SLFN11, especially in cancer cells with impaired DNA repair.
- To identify key factors and pathways involved in SLFN11 activation and its role in cisplatin sensitivity.
Main Methods:
- CRISPR-based genetic screens were employed to identify determinants of cisplatin sensitivity.
- Cellular assays were used to investigate the roles of replication protein A (RPA), primase-polymerase (PrimPol), and the USP1-WDR48 complex in SLFN11 activation.
- Chemical inhibition of DNA polymerase α was used to induce replication stress.
Main Results:
- SLFN11 is critical for cisplatin sensitivity in cells lacking PrimPol-mediated repriming.
- Replication protein A (RPA) exhaustion and single-stranded DNA exposure activate SLFN11 and cell death in PrimPol-deficient cells.
- The USP1-WDR48 deubiquitinase complex positively modulates SLFN11 activation in PrimPol-deficient cells, highlighting a reliance on the Fanconi anaemia pathway.
- Chemical inhibition of DNA polymerase α leads to RPA exhaustion and SLFN11-dependent cell death.
Conclusions:
- Replication protein A (RPA) exhaustion serves as a general mechanism for SLFN11 activation under conditions of heightened replication stress.
- Understanding SLFN11 activation in DNA repair-deficient cells provides potential therapeutic strategies for overcoming chemoresistance in cancer.
Related Concept Videos
Restarting Stalled Replication Forks
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Replicative Cell Senescence
The DNA Replication Fork
Negative Regulator Molecules

